These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32985411)

  • 21. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules.
    Tada T; Miura K; Ikuta A; Ohya M; Shimada T; Osakada K; Takamatsu M; Taguchi Y; Kubo S; Tanaka H; Fuku Y; Kadota K
    EuroIntervention; 2022 Mar; 17(16):1352-1361. PubMed ID: 34483090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
    Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
    Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.
    Coughlan JJ; Aytekin A; Lahu S; Scalamogna M; Wiebe J; Pinieck S; Kufner S; Xhepa E; Joner M; Kuna C; Voll F; Laugwitz KL; Schunkert H; Kastrati A; Cassese S
    EuroIntervention; 2023 Apr; 18(16):e1328-e1338. PubMed ID: 36785947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistant in-stent restenosis in the drug eluting stent era.
    Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    J Interv Cardiol; 2017 Jun; 30(3):195-203. PubMed ID: 28295660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
    Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
    Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation.
    Kim C; Kim BK; Lee SY; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Am Heart J; 2015 Sep; 170(3):591-7. PubMed ID: 26385044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    EuroIntervention; 2017 Jun; 13(3):294-302. PubMed ID: 28320686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis.
    Singh IM; Filby SJ; El Sakr F; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):257-62. PubMed ID: 20665874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Sugi K
    J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical characteristics and prognosis of lesions with in-stent eccentric tissue proliferation and strong signal attenuation detected by optical coherence tomography.
    Suzuki N; Kozuma K; Kyono H; Nakaya H; Nishide S; Mitsui M; Nara Y; Kawashima H; Nomura T; Yamamoto H; Sasajima Y; Kondo F; Isshiki T
    Cardiovasc Interv Ther; 2016 Jul; 31(3):210-7. PubMed ID: 26608163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.
    Feng C; Zhang P; Han B; Li X; Liu Y; Niu D; Shi Y
    Medicine (Baltimore); 2018 Aug; 97(34):e12117. PubMed ID: 30142870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis.
    Chen Z; Matsumura M; Mintz GS; Noguchi M; Fujimura T; Usui E; Seike F; Hu X; Jin G; Li C; Salem H; Fall KN; Shlofmitz E; Kirtane AJ; Cao JJ; Moses JW; Ali ZA; Jeremias A; Shlofmitz RA; Maehara A
    Circ Cardiovasc Interv; 2022 Sep; 15(9):e011693. PubMed ID: 36126137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of baseline plaque characteristic on the development of neoatherosclerosis in the very late phase after stenting.
    Hoshino M; Yonetsu T; Kanaji Y; Usui E; Yamaguchi M; Hada M; Hamaya R; Kanno Y; Murai T; Lee T; Kakuta T
    J Cardiol; 2019 Jul; 74(1):67-73. PubMed ID: 30733110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis.
    Nishihira K; Shibata Y; Ishikawa T; Nomura K; Nakama T; Mine D; Inoue Y; Ashikaga K; Kuriyama N; Matsuyama A; Imamura T; Asada Y; Kitamura K
    Circ J; 2010 Nov; 74(11):2329-33. PubMed ID: 20890050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
    Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
    Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.